Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Vancomycin-resistant S. aureus was cultured from the exit site of a temporary dialysis catheter of a patient with diabetes, peripheral vascular disease, and persistent foot ulcers. The organism carried the vanA resistance gene, which may have come from the vancomycin-resistant Enterococcus faecalis that was also isolated from the patient, who had received vancomycin for several weeks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increasing rates of oxacillin-resistant S aureus or MRSA isolates in both hospital and community settings and the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
In the citing paper
“the recovery of clinical S aureus isolates both partially and fully 138,139 resistant to vancomycin have complicated the treatment of S aureus IE.”
In the citing paper
“and is especially prevalent in North America.6,138,139”
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Diagnostic molecular microbiology : principles and applications
Persing, D. H. (1993) · ASM Press eBooks · Cited by 1,311
Emergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Self-citation(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Arthur, M., Molinas, C., Depardieu, F., & Courvalin, P. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.1.117-127.1993 · Cited by 603
Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus
Bannerman, T. L., Hancock, G. A., Tenover, F. C., & Miller, J. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.551-555.1995 · Cited by 550
Self-citationCharacterization of glycopeptide-resistant enterococci from U.S. hospitals
Clark, N. C., Cooksey, R. C., Hill, B. C., Swenson, J. M., & Tenover, F. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2311 · Cited by 395
Self-citationApplication of pulsed-field gel electrophoresis to molecular epidemiology
Maslow, J. N. (1993) · Medical Entomology and Zoology · Cited by 382
Research works printed but not linked: 7
- 1997, MMWR Morb Mortal Wkly Rep, 46, 624
- 2000, MMWR Morb Mortal Wkly Rep, 48, 1165
- 2002, MMWR Morb Mortal Wkly Rep, 51, 565
- Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, ed. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999:264-82.
- 2001, MMWR Morb Mortal Wkly Rep, 50, 1
- 1995, MMWR Morb Mortal Wkly Rep, 44, 1
- 1997, MMWR Morb Mortal Wkly Rep, 46, 626
Cited by
Items 501–600 of 1,000
Rice, L. B., Laktičová, V., Helfand, M. S., & Hutton‐Thomas, R. (2004) · The Journal of Infectious Diseases · doi:10.1086/425580 · Cited by 29
“With regard to multiresistant enterococci, the primary focus during the last decade has been, understandably, on the emergence and spread of vancomycin resistance; and this focus has been appropriate not only because vancomycin had been considered the last line of defense against resistant enterococci but also because…”
BackgroundBuwchitin: A Ruminal Peptide with Antimicrobial Potential against Enterococcus faecalis
Oyama, L. B., Crochet, J.-A., Edwards, J. E., Girdwood, S. E., Cookson, A., Fernández‐Fuentes, N., Hilpert, K., Golyshin, P. N., Golyshina, O. V., Privé, F., et al. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00051 · Cited by 28
“, 2017) and their potential to spread enterococcal vancomycin resistance to other species remains a concern (Chang et al., 2003).”
BackgroundYoon, Y. K., Lee, M. J., Ju, Y., Lee, S. E., Yang, K., Sohn, J. W., & Kim, M. J. (2019) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-019-0327-8 · Cited by 28
Molecular determination of van genes among clinical isolates of enterococci at a hospital setting
George, S. K., Suseela, M. R., Safi, S. E., Elnagi, E. A., Alnaam, Y., Adam, A. A. M., Jacob, A. M., Al-Maqati, T. N., & S., H. K. K. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.02.022 · Cited by 29
“Investigations have detected the inducible expression of the vanA gene cluster in all these VRSA strains (Cong et al., 2020).”
BackgroundInfluentialEvolution of Antibiotic Resistance Mechanisms and their Relevance to Dialysis-Related Infections
Wong, S. S. Y., Ho, P., & Yuen, K. (2007) · Peritoneal Dialysis International · doi:10.1177/089686080702702s47 · Cited by 28
Islam, T. A. B., & Shamsuzzaman, S. (2015) · Tzu Chi Medical Journal · doi:10.1016/j.tcmj.2014.12.001 · Cited by 30
Chenna, B., King, J. R., Shinkre, B. A., Glover, A. L., Lucius, A. L., & Velu, S. E. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.05.024 · Cited by 29
MRSA Infections: From Classical Treatment to Suicide Drugs
Drebes, J., Künz, M., Pereira, C. A., Betzel, C., & Wrenger, C. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867320666131119122520 · Cited by 33
Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile
Henson, K. E. R., Levine, M. T., Wong, E. A. H., & Levine, D. P. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1068118 · Cited by 33
“The isolate was from an infected catheter exit-site of a 40 year old diabetic woman receiving hemodialysis [19].”
Short-course therapy for bloodstream infections in immunocompetent adults
Corey, G. R., Stryjewski, M. E., & Everts, R. J. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70567-9 · Cited by 33
“In addition, the ability to acquire resistance factors/genes during or around the time of antibiotic treatment can necessitate changes in and prolongation of therapy [19,24].”
BackgroundFernandez, J., Abbanat, D., Shang, W., He, W., Amsler, K. M., Hastings, J., Queenan, A. M., Melton, J. L., Barron, A. M., Flamm, R. K., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06057-11 · Cited by 30
“associating decreased staphylococcal susceptibility to vancomycin and clinical vancomycin treatment failure, including endocarditis indications (8, 29, 59).”
BackgroundEndocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00077-1 · Cited by 40
Yin, Z., Wang, M., Zhang, X., Wu, Z., & Gao, L. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.12.042 · Cited by 32
Iseppi, R., Condò, C., & Messi, P. (2023) · Antibiotics · doi:10.3390/antibiotics12050846 · Cited by 33
“aureus strain isolated in 2002 in the USA, followed by reports of VRSA recovery in other countries, including the European area [40,41].”
BackgroundHoward‐Jones, A. R., Kruger, R. G., Lü, W., Tao, J., Leimkuhler, C., Kahne, D. E., & Walsh, C. T. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0735857 · Cited by 27
Chambers, D., Worthy, G., Myers, L., Weatherly, H. L. A., Elliott, R. A., Hawkins, N., Sculpher, M., & Eastwood, A. J. (2010) · Surgical Infections · doi:10.1089/sur.2009.055 · Cited by 27
“However, vancomycin resistance has been detected in enterococci and S. aureus [4, 5], and MRSA strains with reduced teicoplanin susceptibility have been identified in the U.K. [6] and France [7].”
Community-acquired vancomycin-resistant Enterococcus faecium: a case report from Malaysia
Raja, N. S., Karunakaran, R., Ngeow, Y. F., & Awang, R. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46169-0 · Cited by 31
“aureus possessing the vanA gene have been reported from clinical settings (Chang et al., 2003; Tenover et al., 2004; CDC, 2004).”
BackgroundInfluentialBurnside, K. L., Lembo, A., Harrell, M. I., Klein, J. A., López-Guisa, J. M., Siegesmund, A. M., Torgerson, T. R., Oukka, M., Molina, D. M., & Rajagopal, L. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis579 · Cited by 28
Ventilator-associated pneumonia in burn patients: a cause or consequence of critical illness?
Huzar, T. F., & Cross, J. M. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.61 · Cited by 27
Miyoshi, N., Isogai, E., Hiramatsu, K., & Sasaki, T. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2016.101 · Cited by 29
Double-Stranded RNA Is a Novel Molecular Target in Osteomyelitis Pathogenesis
Greene, E., Flees, J. J., Dhamad, A. E., Alrubaye, A. A. K., Hennigan, S., Pleimann, J., Smeltzer, M. S., Murray, S., Kugel, J. F., Goodrich, J. A., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.06.013 · Cited by 27
Infectious Complications of Dialysis Access Devices
Bagdasarian, N., Heung, M., & Malani, P. (2012) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2011.09.005 · Cited by 27
Niederhäusern, S. D., Sabia, C., Messi, P., Guerrieri, E., Manicardi, G. C., & Bondi, M. (2004) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2004.01598.x · Cited by 27
“The ª 2004 The Society for Applied Microbiology, Letters in Applied Microbiology, 39, 483–489, doi:10.1111/j.1472-765X.2004.01598.x VRSA carried the vanA gene deriving from an E. faecalis strain, isolated from the same patient after several weeks of vancomycin treatment (Chang et al. 2003).”
BackgroundInfluentialDiagnosis of central venous catheter related infection in adult patients
Worthington, T., & Elliott, T. S. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.06.007 · Cited by 33
Vancomycin-Resistant Enterococcus : Risk Factors, Surveillance, Infections, and Treatment
Mazuski, J. E. (2008) · Surgical Infections · doi:10.1089/sur.2008.9955 · Cited by 27
“There have been reports of such transmission, the first case being reported in 2003 [7].”
Ouyang, Y., Tang, X., Zhao, Y. H., Zuo, X., Ren, X., Wang, J., Zou, L., & Lu, J. (2023) · Antioxidants · doi:10.3390/antiox12061180 · Cited by 30
“aureus have evolved resistance to nearly all common classes of antibiotics including β-lactams, aminoglycosides, macrolides, tetracyclines and quinolones [49].”
BackgroundEl catéter periférico: el gran olvidado de la infección nosocomial
Capdevila, J. A. (2013) · Revista española de quimioterapia. Suplemento · Cited by 57
Structural features and kinetic characterization of alanine racemase fromStaphylococcus aureus(Mu50)
Scaletti, E. R., Luckner, S. R., & Krause, K. L. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911050682 · Cited by 30
Marcadé, G., Micol, J., Jacquier, H., Raskine, L., Donay, J., Nicolas-Viaud, S., Rouveau, M., Ribaud, P., Dombret, H., Leclercq, R., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt376 · Cited by 26
Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection
Axelrad, J. E., Lebwohl, B., Cuaresma, E., Cadwell, K., Green, P. H. R., & Freedberg, D. E. (2018) · Gut Pathogens · doi:10.1186/s13099-018-0259-4 · Cited by 26
Schmidt, S., Sabarinath, S., Barbour, A., Abbanat, D., Manitpisitkul, P., Sha, S., & Derendorf, H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-09 · Cited by 26
“However, with the appearance of vancomycin-resistant strains, for example, vancomycin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, the once powerful antibiotic arsenal is becoming increasingly ineffective (3, 12).”
BackgroundA guide to antibiotic resistance in bacterial skin infections
Perera, G., & Hay, R. J. (2005) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2005.01296.x · Cited by 26
Jiang, Y., Xu, Q., Jiang, L., & Zheng, R. (2021) · Intervirology · doi:10.1159/000515282 · Cited by 26
Enterococcus and its Association with Foodborne Illness
Oprea, S. F., & Zervos, M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-501-5_6 · Cited by 31
Rapid detection of antibacterial resistance in emerging Gram-positive cocci
Metan, G., Zarakolu, P., & Ünal, S. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.02.020 · Cited by 25
Spiliopoulou, I. T., & Petinaki, E. (2015) · Veterinary Medicine Research and Reports · doi:10.2147/vmrr.s91313 · Cited by 37
Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review
Ellis, M. W. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s46 · Cited by 26
“Not long after, the fi rst report of vancomycin-resistant S. aureus (VRSA) was described in a patient from Michigan; since that time, several other strains of VRSA have emerged (Sievert et al 2002; Chang et al 2003a).”
Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada
Webster, D., Rennie, R. P., Brosnikoff, C., Chui, L., & Brown, C. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.07.007 · Cited by 26
Molecular Mechanisms of Antibiotic Resistance in Bacteria
Opal, S. M., & Pop-Vicas, A. E. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00018-7 · Cited by 41
Zhu, L., Zhang, Z.-W., Wang, C., Yang, H.-W., Zhang, Q., & Cheng, J. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01522.x · Cited by 27
Heinzinger, L. R., Pugh, A. R., Wagner, J. A., & Otto, M. J. (2023) · Antibiotics · doi:10.3390/antibiotics12081256 · Cited by 25
“Antibiotics used in farm animals account for approximately 73% of all antibiotic use [147,155]; in the United States, that number rises to 80% [156].”
BackgroundPrevention of Health Care-Associated Infections
Diekema, D. J., & Pfaller, M. A. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch8 · Cited by 25
Al-Obeid, S., Haddad, Q., Cherkaoui, A., Schrenzel, J., & François, P. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00954-09 · Cited by 24
“aureus strains (VRSA) were confirmed in the United States (10, 38).”
BackgroundPeng, K., Huang, T., Chiang, Y., Hsu, Y.-Y., Chuang, F.-Y., Lee, C., & Chang, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060816 · Cited by 23
Elahi, Y., Nowroozi, J., & Fard, R. M. N. (2021) · Iranian Journal of Microbiology · doi:10.18502/ijm.v13i5.7434 · Cited by 23
Detection and Characterization of Antimicrobial Resistance Genes in Pathogenic Bacteria
Rasheed, J. K., & Tenover, F. C. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch74 · Cited by 25
Self-citationRole of Wall Teichoic Acids in Staphylococcus aureus Endophthalmitis
Suzuki, T., Campbell, J., Swoboda, J. G., Walker, S., & Gilmore, M. S. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6558 · Cited by 23
Novel pharmaceutical molecules against emerging resistant gram-positive cocci
Manfredi, R., & Sabbatani, S. (2010) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(10)70020-9 · Cited by 27
Hetem, D. J., Rooijakkers, S. H. M., & Ekkelenkamp, M. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00176-3 · Cited by 38
Antibiotic Resistance in the Staphylococci
Projan, S. J., & Ruzin, A. V. (2014) · ASM Press eBooks · doi:10.1128/9781555816513.ch48 · Cited by 25
Treatment of Infections Caused By Antimicrobial-Resistant Gram-Positive Bacteria
Kinney, K. K. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181e99aa4 · Cited by 25
De Novo Formal Synthesis of (−)-Virginiamycin M2 via the Asymmetric Hydration of Dienoates
Mortensen, M. S., Osbourn, J. M., & O'Doherty, G. A. (2007) · Organic Letters · doi:10.1021/ol071145e · Cited by 23
Tabuchi, F., Matsumoto, Y., Ishii, M., Tatsuno, K., Okazaki, M., Sato, T., Moriya, K., & Sekimizu, K. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.7 · Cited by 23
“2 Chang, S. et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348, 1342–1347 (2003). 3 Melo-Cristino, J., Resina, C., Manuel, V., Lito, L. & Ramirez, M. First case of infection with vancomycin-resistant Staphylococcus aureus in Europe. Lancet 382, 20…”
Fraimow, H. S., Knob, C., Herrero, I. A., & Patel, R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2625-2633.2005 · Cited by 23
Decline in Invasive MRSA Infection: Where to Go From Here?
Perencevich, E. N., & Diekema, D. J. (2010) · JAMA · doi:10.1001/jama.2010.1125 · Cited by 26
Bland, C. M., Porr, W. H., Davis, K. A., & Mansell, K. B. (2010) · Southern Medical Journal · doi:10.1097/smj.0b013e3181efb5b1 · Cited by 22
Chieffi, D., Fanelli, F., & Fusco, V. (2023) · Frontiers in Food Science and Technology · doi:10.3389/frfst.2023.1165871 · Cited by 22
Almutairi, H., Albahadel, H., Alhifany, A. A., Aldalbahi, H., Alnezary, F. S., Alqusi, I., Mobark, M. A., & Almutairi, M. S. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102001 · Cited by 28
“However, despite the current susceptibility, continued monitoring for any shifts is advisable (Zorgani et al., 2015) given sporadic but concerning global reports of decreasing susceptibility and emerging resistance among some MRSA strains (Chang et al., 2003, Amatya et al., 2014).”
Gürtler, V., Grando, D., Mayall, B. C., Wang, J., & Ghaly-Derias, S. (2012) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2012.05.002 · Cited by 25
Verkade, E. J. M., Verhulst, C., Huijsdens, X. W., & Kluytmans, J. A. J. W. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0886-2 · Cited by 22
Small-Molecule Inhibitors of Staphylococcus aureus RnpA-Mediated RNA Turnover and tRNA Processing
Eidem, T. M., Lounsbury, N., Emery, J. F., Bulger, J. L., Smith, A. H., Abou-Gharbia, M. A., Childers, W. E., & Dunman, P. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04352-14 · Cited by 23
Ali, S., Alemayehu, M., Dagnew, M., & Gebrecherkos, T. (2018) · International Journal of Microbiology · doi:10.1155/2018/4753460 · Cited by 22
“In addition, in recent years, these genes have been transferring resistant genes to methicillin-resistant Staphylococcus aureus to form VRSA, thereby causing failure to treatment [23, 24].”
BackgroundResistance to Glycopeptide Antibiotics
Lebreton, F., & Cattoir, V. (2019) · Wiley eBooks · doi:10.1002/9781119593522.ch3 · Cited by 22
Molecular Dynamics Simulation of Atomic Interactions in the Vancomycin Binding Site
Olademehin, O. P., Kim, S. J., & Shuford, K. L. (2020) · ACS Omega · doi:10.1021/acsomega.0c05353 · Cited by 22
An optimization model for antibiotic use
Massad, E., Burattini, M. N., & Coutinho, F. A. B. (2008) · Applied Mathematics and Computation · doi:10.1016/j.amc.2007.12.007 · Cited by 27
“Examples are transferable quinolone resistance in enterobacteria [22], vancomycin-resistant staphilococcus [23] and multidrug resistant Yersinia pestis [24].”
BackgroundSynergy of Arbekacin-based Combinations Against Vancomycin Hetero-intermediate Staphylococcus aureus
Lee, J.-Y., Oh, W. S., Ko, K. S., Heo, S. T., Moon, C. S., Ki, H. K., Kiem, S., Peck, K. R., & Song, J. (2006) · Journal of Korean Medical Science · doi:10.3346/jkms.2006.21.2.188 · Cited by 22
Chen, Y., Shi, Y., Zhu, W., You, J., Yang, J., Xie, Y., Zhao, H., Li, H., Fan, S., Li, L., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.742040 · Cited by 24
Genome‐scale metabolic representation of Amycolatopsis balhimycina
Vongsangnak, W., de Figueiredo, L. F., Förster, J., Weber, T., Thykær, J., Stegmann, E., Wohlleben, W., & Nielsen, J. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24436 · Cited by 24
“aureus (VRSA) strains (Chang et al., 2003; Chamber and Deleo, 2009; Gunnarsson, 2004a; Pearson, 2002) and there is hence a need for novel antibiotics.”
BackgroundMicrobial profile of diabetic foot infections in Trinidad and Tobago
Islam, S., Cawich, S. O., Budhooram, S., Harnarayan, P., Mahabir, V., Ramsewak, S., & Naraynsingh, V. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.05.001 · Cited by 21
Heizmann, W. R., Dupont, H., Montravers, P., Guirao, X., Eckmann, C., Bassetti, M., García, M. S., Capparella, M. R., Simoneau, D., & Bodmann, K. ‐. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt144 · Cited by 23
Schaad, H. J., Bento, M., Lew, D. P., & Vaudaux, P. E. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-74 · Cited by 22
“aureus (MRSA) displaying multidrug resistance not only against all semi-synthetic penicillins and penems, but also frequently against macrolides, aminoglycosides, fluoroquinolones [2-4], and glycopeptides [3,5-7] recently prompted the development of novel antimicrobial agents active against such dangerous pathogens.”
BackgroundBernard, L., Vaudaux, P. E., Rohner, P., Huggler, E., Armanet, M., Pittet, D., Lew, D. P., & Schrenzel, J. (2004) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2004.01.012 · Cited by 27
Vancomycin-resistant Enterococcus – A Review From a Singapore Perspective
Chlebicki, M. P., & Kurup, A. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n10p861 · Cited by 27
Horstkotte, M. A., Knobloch, J. K. ‐., Rohde, H., Dobinsky, S., & Mack, D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5041-5046.2004 · Cited by 24
“However, antistaphylococcal penicillins are the drugs of choice because of unexcelled activity and low toxicity and in order to reduce the possibility of the emergence of vancomycin-resistant CoNS, Staphylococcus aureus, and enterococci (6, 7, 31, 36, 37, 45).”
BackgroundAntibacterial Susceptibility Testing in the Clinical Laboratory
Holland, T. L., Woods, C. W., & Joyce, M. J. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.06.001 · Cited by 24
“More recently, the first fully vancomycin-resistant (MIC 32 lg/mL)S aureus isolates containing the vanA resistance gene from enterococci were identified in the United States [75,76].”
BackgroundCycoń, M., Borymski, S., Orlewska, K., Wąsik, T. J., & Piotrowska‐Seget, Z. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01015 · Cited by 22
“Moreover, the first resistant strain of vancomycin-resistant S. aureus was reported in 2002 (Chang et al., 2003).”
BackgroundInfluence of Linezolid Clearance on the Induction of Thrombocytopenia and Reduction of Hemoglobin
Hiraki, Y., Tsuji, Y., Matsumoto, K., Morita, K., Kamimura, H., & Karube, Y. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318218cf18 · Cited by 20
Santos‐Beneit, F., & Martı́n, J. F. (2013) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2013.03.003 · Cited by 20
“coelicolor [2–4].”
BackgroundPark, J. W., Lee, H., Kim, J. W., & Kim, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-42307-6 · Cited by 20
Cheng, A. V., Kim, W., Escobar, I. E., Mylonakis, E. E., & Wuest, W. M. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00159 · Cited by 20
The staphylococcal elastin-binding protein regulates zinc-dependent growth/biofilm formation
Nakakido, M., Aikawa, C., Nakagawa, I., & Tsumoto, K. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu027 · Cited by 23
Luo, J., Yan, D., & Yang, M. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60049-2 · Cited by 21
“Recently, with reports of the clinical and microbiological failure of vancomycin in MRSA infections, the efficacy of vancomycin in the treatment of these infections has also been called into question ([8-10]).”
BackgroundSunduru, N., Gupta, L., Chauhan, K., Mishra, N. N., Shukla, P. K., & Chauhan, P. M. S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.044 · Cited by 20
Inhibiting platelets aggregation could aggravate the acute infection caused byStaphylococcus aureus
Zhang, X., Liu, Y., Gao, Y., Dong, J., Mu, C., Lu, Q., Shao, N., & Yang, G. (2011) · Platelets · doi:10.3109/09537104.2010.543962 · Cited by 20
Combined Pharmacophore and 3D‐QSAR Study on A Series of Staphylococcus aureus Sortase A inhibitors
Uddin, R., Lodhi, M. U., & Ul‐Haq, Z. (2012) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2012.01403.x · Cited by 25
“However, SrtA strains with vancomycin can cause infections for which antimicrobial treatment may no longer be useful (17).”
BackgroundVancomycin resistance: are there better glycopeptides coming?
Linden, P. K. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.6.917 · Cited by 23
Hart, M. E., Tsang, L. H., Deck, J., Daily, S. T., Jones, R. C., Liu, H., Hu, H., Hart, M. J., & Smeltzer, M. S. (2013) · Microbiology · doi:10.1099/mic.0.065367-0 · Cited by 22
“…is compounded further by the occurrence of clinical strains resistant to intermediate (Hiramatsu et al., 1997; Srinivasan et al., 2002) and high (Chang et al., 2003; Tenover et al., 2004; Whitener et al., 2004) levels of vancomycin, an antibiotic of last resort for infections involving multiple…”
BackgroundIn Vivo Release of Vancomycin from Calcium Phosphate Cement
Uchida, K., Sugo, K., Nakajima, T., Nakawaki, M., Takano, S., Nagura, N., Takaso, M., & Urabe, K. (2018) · BioMed Research International · doi:10.1155/2018/4560647 · Cited by 20
“However, long term use of CPC/VCM may be associated with problems such as resistance among staphylococci, including vancomycin-intermediate Staphylococcus aureus (VISA) [23], heteroresistant vancomycinintermediate Staphylococcus aureus strains (hVISA) [24], and vancomycin-resistant Staphylococcus aureus (VRSA) [25], a…”
BackgroundHibbitts, A., Lucía, A., Serrano‐Sevilla, I., Matteis, L. D., McArthur, M., de la Fuente, J. M., Aínsa, J. A., & Navarro, F. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220684 · Cited by 21
Current Trends of Emergence and Spread of Vancomycin-Resistant Enterococci
Werner, G. (2012) · InTech eBooks · doi:10.5772/29791 · Cited by 30
“The first clinical vanA-mediated high-level vancomycinresistant MRSA (VRSA) was isolated from a dialysis patient in Michigan, USA (Weigel et al., 2003; Chang et al., 2003).”
BackgroundVonberg, R., Chaberny, I. F., Kola, A., Mattner, F., Borgmann, S., Dettenkofer, M., Jonas, D., Fahr, A.-M., Klare, I., Werner, G., et al. (2006) · Der Anaesthesist · doi:10.1007/s00101-006-1123-3 · Cited by 19
Diagnóstico laboratorial da resistência à oxacilina em Staphylococcus aureus
Mimiça, M. J., & Mendes, C. M. F. (2007) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442007000600003 · Cited by 39
High-Level Vancomycin-Resistant Staphylococcus aureus (VRSA) in Iran: A Systematic Review
Askari, E., Zarifian, A., Pourmand, M. R., & Naderinasab, M. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 25
Elsawy, S., Elsherif, W. M., & Hamed, R. A. A. (2021) · Pathogens and Global Health · doi:10.1080/20477724.2021.1914412 · Cited by 19
“Its efficacy remains dominant, provided that bacterial resistance is under control, as contemporary antimicrobials with a higher efficacy are not yet obtainable [24].”
BackgroundZuo, G., Han, Z.-Q., Han, J. H., Hao, X., Tang, H.-S., & Wang, G.-C. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12433 · Cited by 19
Kihara, R., Yanagihara, K., Morinaga, Y., Araki, N., Nakamura, S., Seki, M., Izumikawa, K., Kakeya, H., Yamamoto, Y., Tsukamoto, K., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01532-07 · Cited by 19
“them, an association with vanA-containing enterococci at the same site in the affected patients could be established (2).”
BackgroundMeyer, E., Ziegler, R., Mattner, F., Schwab, F., Gastmeier, P., & Martin, M. (2011) · Infection · doi:10.1007/s15010-011-0154-0 · Cited by 19
“Generally, the clinical importance of VRSA has been highlighted by the reports of VRSA occurring as a result of the transfer of the vanA gene from VRE [9].”
BackgroundCryptic resistance in Staphylococcus aureus: a risk for the treatment of skin infection?
Saeed, K. B. A., Marsh, P., & Ahmad, N. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000046 · Cited by 22
Study of enterococcal susceptibility patterns isolated from clinical specimens in Tabriz, Iran.
Akhi, M. T., Farzaneh, F., & Oskouei, M. B. (2009) · Pakistan Journal of Medical Sciences · Cited by 21
Has vancomycin-resistant Staphylococcus aureus started going it alone?
Hiramatsu, K., Cui, L., & Kuwahara‐Arai, K. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16867-0 · Cited by 19
Metadata
- Authors
- Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., Cardo, D., & Fridkin, S. K.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Michigan Department of Health and Human Services (US)
- Wayne State University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1342-1347
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2068037991
- Semantic Scholar
- f0afb59f819a65ada63076a36807f63502c4437d
- Cited by
- 1,095
- References
- 18
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 24 · 2023: 28 · 2022: 24 · 2021: 35 · 2020: 29 · 2019: 39 · 2018: 28 · 2017: 29 · 2016: 28 · 2015: 55 · 2014: 54 · 2013: 51 · 2012: 65
- FWCI
- 54.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- vancomycin-resistant Staphylococcus aureus, vanA gene, vancomycin resistance, diabetes mellitus, peripheral vascular disease, foot ulcer, vancomycin-resistant Enterococcus faecalis, antibiotic resistance transfer, catheter-related infection
- MeSH terms
- Adult, Catheterization, Debridement, Female, Renal Dialysis, Humans, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Contact Tracing, Diabetic Foot, Vancomycin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.